All Episodes
Endo in a Bite — 45 episodes
AHA ACA - Lipoprotein Goals for ASCVD Risk Reduction (Part 1)
AHA ACC - Lipoprotein(a), Apolipoprotein B, and Cardiovascular Risk Stratification
AHA ACC Measurement of TC, LDL C, HDL C, TG, and Non-HDL C
AHA ACC Screening For Dyslipidemia In Children And Adults
Hypoglycemia (ADA Standards of Care; Mentioned in ESAP 2026)
Vitamin D (Endocrine Society 2024; Mentioned in ESAP 2026)
Key Clinical Points on Semaglutide (ESAP 2026)
Cardiovascular Kidney Metabolic Syndrome (AHA 2023; Mentioned in ESAP 2026)
The PREVENT Calculator and Lipid Risk Enhancers (Mentioned in ESAP 2026)
Obesity: Part 8 (Individualized Pharmacotherapy - 2025 AACE Update)
Obesity: Part 7 (Cost Conscious Pharmacotherapy - 2025 AACE Update)
Obesity: Part 6 (Complication Centric Pharmacotherapy - 2025 AACE Update)
Obesity: Part 5 (Lifestyle Therapy and Long Term Management - 2025 AACE Update)
Obesity: Part 4 (Response and Targets - 2025 AACE Update)
Obesity: Part 3 (Clinical Component of ABCD - 2025 AACE Update)
Obesity: Part 2 (Anthropometric Component of ABCD - 2025 AACE Update)
Obesity: Part 1 ( Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity Based Chronic Disease - 2025 AACE Update)
Management of Dyslipidemia: Part 10 (Special Populations)
Management of Dyslipidemia: Part 9 (Statins & LDL Lowering Therapy)
Management of Dyslipidemia: Part 8 (High TG in Pregnancy)
Management of Dyslipidemia: Part 7 (High TG Treatment)
Management of Dyslipidemia: Part 6 (High TG Classification)
Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 5)
Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 4)
Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 3)
Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 2)
Algorithm for Management of Dyslipidemia - 2025 AACE Update (Part 1)
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 10
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 9
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 8
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 7
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 6
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 5
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 4
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 3
New Primary Aldosteronism – Endocrine Society 2025 Guidelines; Bonus Summary Episode 5
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 2
New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 4
2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer – Part 1
New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 3 of 4
New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 2 of 4
New Primary Aldosteronism Guidelines – Endocrine Society 2025; Episode 1 of 4
Lipoprotein(a): What Every Endocrinologist Should Know
MASLD & MASH: Concise Clinical and Board Pearls
Vaccines in Patients with Diabetes